Pharma BD Deal Intelligence

McKesson Corporation / Precision Medicine Group, LLC

2026 · Acquisition/Merger · $2.2B · Pending

McKesson Corporation signed a definitive agreement to acquire Precision Medicine Group, LLC, a Bethesda, Maryland-based global provider of clinical research and biopharma commercialization services, for approximately $2.25 billion. Precision Medicine Group's offering spans biomarker intelligence, laboratory services, a global contract research organization, market access consulting and commercialization support for biotechnology and pharmaceutical companies. Following completion, Precision Medicine Group will report within McKesson's Oncology & Multispecialty segment. The transaction is subject to customary closing conditions, including regulatory clearances. NOTE: ingested at pending_review by bd-enrichment 2026-08-26.

This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2031 at the earliest for this deal, once/if it closes.

Key facts

Related deals

See the full interactive analysis, sources & comparables →

← Browse all deals  ·  How we score deals

More: 2026 deals